Stockscreener 앱 받기
17.51
0.57%
0.10
시장 영업 전:
17.96
0.45
+2.57%
전일 마감가:
$17.41
열려 있는:
$17.34
하루 거래량:
1.56M
Relative Volume:
1.02
시가총액:
$3.05B
수익:
-
순이익/손실:
$-382.71M
주가수익비율:
-6.6832
EPS:
-2.62
순현금흐름:
$-325.64M
1주 성능:
+2.82%
1개월 성능:
+15.88%
6개월 성능:
+15.58%
1년 성능:
-40.16%
1일 변동 폭
$17.02
$17.59
1주일 범위
$16.77
$18.38
52주 변동 폭
$12.72
$32.10
Immunovant Inc Stock (IMVT) Company Profile
명칭
Immunovant Inc
전화
917-580-3099
주소
320 WEST 37TH STREET, NEW YORK, NY
IMVT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMVT
Immunovant Inc
|
17.51 | 3.03B | 0 | -382.71M | -325.64M | -2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | Truist | Hold |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-03-03 | 개시 | Jefferies | Hold |
| 2025-01-03 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-10-09 | 재확인 | Oppenheimer | Outperform |
| 2024-03-28 | 개시 | Oppenheimer | Outperform |
| 2024-03-13 | 개시 | Goldman | Buy |
| 2024-02-20 | 개시 | JP Morgan | Overweight |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-10-13 | 업그레이드 | UBS | Neutral → Buy |
| 2023-09-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-01 | 개시 | BofA Securities | Buy |
| 2023-04-25 | 개시 | Citigroup | Buy |
| 2023-03-31 | 개시 | Piper Sandler | Overweight |
| 2023-03-30 | 개시 | Stifel | Buy |
| 2023-02-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-01-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-09-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-08 | 개시 | Wells Fargo | Equal Weight |
| 2021-08-03 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2021-08-02 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2021-06-01 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-06-01 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-10-28 | 개시 | UBS | Buy |
| 2020-10-12 | 개시 | Guggenheim | Buy |
| 2020-10-08 | 개시 | Stifel | Buy |
| 2020-10-02 | 개시 | Credit Suisse | Outperform |
| 2020-08-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-25 | 개시 | Raymond James | Outperform |
| 2020-07-29 | 개시 | H.C. Wainwright | Buy |
| 2020-02-24 | 개시 | SVB Leerink | Outperform |
모두보기
Immunovant Inc 주식(IMVT)의 최신 뉴스
Why Immunovant Inc. stock is popular among millennialsMarket Volume Report & Low Drawdown Momentum Trade Ideas - newser.com
Trend analysis for Immunovant Inc. this week2025 Price Targets & Free Verified High Yield Trade Plans - newser.com
Can Immunovant Inc. stock continue upward trendJuly 2025 Patterns & Entry Point Strategy Guides - nchmf.gov.vn
What analyst consensus says on Immunovant Inc. stockOptions Play & AI Driven Stock Price Forecasts - nchmf.gov.vn
Why Immunovant Inc. stock remains undervalued2025 Buyback Activity & Consistent Return Investment Signals - nchmf.gov.vn
Why Immunovant Inc. stock attracts global investorsBear Alert & AI Enhanced Trading Alerts - nchmf.gov.vn
What sentiment indicators say about Immunovant Inc. stockWeekly Risk Summary & Low Volatility Stock Suggestions - nchmf.gov.vn
Published on: 2025-10-18 11:37:29 - nchmf.gov.vn
Published on: 2025-10-18 07:11:53 - nchmf.gov.vn
Will Immunovant Inc. stock outperform value stocksWeekly Trend Recap & Long-Term Safe Investment Plans - newser.com
Visualizing Immunovant Inc. stock with heatmapsWeekly Loss Report & Consistent Return Investment Signals - newser.com
Reversal indicators forming on Immunovant Inc. stockTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Key resistance and support levels for Immunovant Inc.Quarterly Trade Report & Community Consensus Trade Alerts - newser.com
Truist Securities initiates Immunovant stock with Hold rating, $16 target - Investing.com
Statistical indicators supporting Immunovant Inc.’s strengthJuly 2025 Movers & Expert Approved Momentum Ideas - newser.com
How analysts rate Immunovant Inc. stock todayJuly 2025 Review & Free Technical Pattern Based Buy Signals - newser.com
Analyzing drawdowns of Immunovant Inc. with statistical toolsPortfolio Growth Summary & Stock Timing and Entry Methods - newser.com
How hedge fund analytics apply to Immunovant Inc. stockDollar Strength & Short-Term Trading Alerts - newser.com
Immunovant (NASDAQ:IMVT) Insider Michael Geffner Sells 1,272 Shares - MarketBeat
Immunovant (NASDAQ:IMVT) Shares Up 7.2%Here's What Happened - MarketBeat
Immunovant’s chief technology officer sells $25,835 in stock By Investing.com - Investing.com South Africa
Immunovant’s chief technology officer sells $25,835 in stock - Investing.com India
Will breakout in Immunovant Inc. lead to full recovery2025 Technical Patterns & AI Driven Price Predictions - newser.com
Immunovant Inc. stock momentum explainedMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
Smart tools for monitoring Immunovant Inc.’s price action2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 - MSN
Published on: 2025-10-09 06:28:21 - newser.com
Using Ichimoku Cloud for Immunovant Inc. technicalsMarket Activity Summary & Real-Time Volume Analysis Alerts - newser.com
Is Immunovant Inc. forming a bottoming baseJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Immunovant Inc (IMVT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):